The relationship between healthcare utilization before and after liver transplantation 
considers recipient case-mix could also serve as a benchmark to assess LT-center performance. This first requires a better understanding of center variability in post-LT healthcare utilization, and of the center factors associated with increased post-LT rehospitalization. The primary aims of this study were threefold: (1) to describe post-LT healthcare utilization over the first year in a large representative population; (2) to determine whether pre-LT hospitalization is an independent predictor of the number of days alive and out of the hospital (DAOH) in the first post-LT year; and (3) to isolate center characteristics associated with increased healthcare utilization post-LT.
| METHODS

| Study design and population
This was a retrospective cohort study using Vizient inpatient claims data linked to the United Network for Organ Sharing (UNOS) database. The linking procedure has been described previously. Subjects were excluded if they were status 1 or if they underwent multiorgan transplantation other than simultaneous liver-kidney (SLK) because the MELD score is not the basis for waitlist prioritization in these patients. Furthermore, subjects transplanted at centers performing fewer than100 LTs during the study period (less than on average 10 per year) were excluded to reduce bias from between-center variability of estimates for small centers.
| Study variables
The primary exposure was the cumulative number of days hospitalized 90 days pre-LT. This was chosen for the following two reasons:
(1) hospitalization in the 90 days pre-LT predicts post-LT outcomes, 6 and (2) to minimize missing data because hospitalizations at non-UHC The primary outcome was DAOH in the first LT year. DAOH as a metric of healthcare utilization is well-validated in cardiology. [13] [14] [15] [16] DAOH was defined as the number of days alive minus the number of days hospitalized during the first LT year. DAOH accounts for morbidity by capturing the duration of all hospitalizations, as well as mortality, while putting a greater emphasis on early deaths. 13 Post-LT hospitalizations were evaluated over the first year, as they are more likely to occur at the transplanting center due to recipients' complex management, and as admission decisions during this time frame are more likely to be at the discretion of the LT center. The LOS between LT date and hospital discharge date among patients alive at discharge (LT-LOS) was evaluated as a secondary outcome.
Hospitalizations were defined as an inpatient encounter with LOS of 2 days minimum, excluding observation encounters, emergency room visits, and short-term admissions for procedures. 4 Only hospitalizations occurring at the LT center were available. Post-LT deaths were identified by confirmed Social Security Death Master File death date in UNOS.
| Statistical analysis
To assess for external validity, subject characteristics were compared between those included in the study cohort and subjects transplanted at non-UHC hospitals who met the inclusion/exclusion criteria.
Multivariable mixed-effects linear regression with transplant centerlevel random intercepts evaluated the association between pre-LT healthcare utilization and DAOH at 1-year post-LT for the primary analysis, and LT-LOS for the secondary analysis. Mixed-effects regression accounted for clustering of outcomes within transplant centers.
All models used robust standard errors.
All models were also adjusted for the following pre-specified 
| RESULTS
The final study cohort included 34 402 LTs. The demographic and clinical characteristics of the study cohort were overall not different from non-UHC patients transplanted over the same period (Table 1) .
LT centers from all UNOS regions were represented in the study cohort, but in regions 2, 4, 6, 9, and 11 <50% of LT centers were captured. 
| Pretransplant healthcare utilization
| Posttransplant healthcare utilization
Ascites at LT, N (%) Severity of illness at the time of LT was associated with increasing LT-LOS (Table S1 ). The strongest predictor of LT-LOS was pre-LT 
| Center variability in healthcare utilization after LT
Of the 32 547 recipients surviving the first 3 months post-LT, 24.5%
were hospitalized ≥30 days and defined as high HRU recipients.
Among the 62 LT centers, the median proportion of high HRU recipients was 25.83% (IQR 19.13-30.5%). Center variability in the proportion of high HRU recipients by UNOS region adjusted for recipient case-mix is shown in Figure 2 ; this ranged from 11.72% of LTs to 45.27%. Centers were divided into 3 tiers: (1) low HRU centers (N = 17), having <20% of high HRU recipients; (2) average HRU centers (N = 28), having 20%-30%; and (3) high HRU centers (N = 17), having >30% high HRU recipients. Table 3 
| DISCUSSION
The goal of LT is to bring patients back to a state of high functioning, not of continued chronic illness. The identification of patients at risk for poor outcomes despite life-saving LT is important for proper candidate selection in extreme circumstances. In day-to-day practice, this information can also provide anticipatory guidance to patients, to LT center performance has been assessed primarily by differences in observed to expected patient and graft survival over the first year.
Although such statistics represent easy targets for intervention, they do not consider post-LT morbidity, which is also of great value to patients when selecting where to receive care. A comprehensive assessment of center post-LT morbidity and mortality that also factors center case-mix and volume could allow high-performing centers to be identified. This could serve as a valuable tool to help improve recipient quality of life and care practices overall, more so than as a metric for punitive purposes that could lead to more conservative listing and organ-acceptance practices.
Wilson et al were the first to assess center variability in post-LT healthcare utilization, demonstrating a 2.37-fold difference in the process, but may have greater infrastructure challenges in addressing post-LT issues on an outpatient basis. Moreover, surgical experience is a well-known predictor of postoperative healthcare utilization.
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High HRU centers were not more prone to use DCD organs, do- could not be assessed, these findings argue that there were minimal temporal changes in center behavior overall.
In other surgical subspecialties, hospital care practices influence postoperative healthcare utilization and are used as a benchmark for healthcare quality. [24] [25] [26] In this study, marked variability in pre-LT healthcare utilization was seen among centers, which did not follow any particular regional distribution and was incompletely explained by center median MELD score at LT. Unlike many other markers of severity of illness, the readmission risk in patients with ESLD is modifiable. Median lab MELD at LT (IQR) 19 (18) (19) (20) 18.5 (17) (18) (19) (20) 20 (19) (20) (21) .022
Median proportion of recipients with lab MELD ≥35 at LT, % (IQR) to reevaluate their risk-taking practices. This will facilitate the development of center-based guidelines and policies that reduce pre-LT risk factors, and improve post-LT morbidity and mortality. Although our study focused only on healthcare utilization in the first year after LT, further research should also investigate post-LT inpatient needs over longer time horizons.
Using hospital days, rather than admission number, the duration and intensity of inpatient needs were accounted for in this study.
Although cost data were available from the dataset, this research sought to focus on patient-centered outcomes rather than the financial repercussions of performing transplantations in "sicker" patients.
Moreover, there were concerns over the generalizability of the cost data available, which would be expected to vary geographically independent of candidate severity of illness. It is worth noting that pre-LT hospitalization was significantly associated with MELD score in our cohort, the latter of which being a well-established determinant of LT-related costs. [31] [32] [33] [34] By simultaneously providing an assessment of morbidity and mortality, the use of DAOH as a post-LT outcome is novel and should be further validated in future LT-related research. In addition, this metric avoids the exclusion of early deaths from analyses, unlike in prior studies. LT nor the benefit of LT on DAOH could be explored. This warrants further study such as via a cost-effectiveness analysis. Moreover, details related to perioperative events were not available, yet may have significantly influenced the need for post-LT rehospitalization. 6 As an exploratory analysis, changes in R 2 were compared when adding laboratory MELD versus 90-day pre-LT hospital days to the primary model. The number of days hospitalized in the 90 days prior to LT was as strong of a predictor of DAOH as the MELD score (absolute incremental increase in R 2 of 0.1% for each). However, it should also be noted that the absolute increase in R 2 for both covariates is very low. Moreover, the low R 2 for the model overall indicates that there is substantial unexplained residual variability. This is likely because other important clinical events, such as perioperative complications and posttransplantation management, also influence post-LT outcomes to a great degree. These issues could not be evaluated in greater detail in this study and is a limitation of this research that warrants further study.
In conclusion, pre-LT hospitalization independently predicts recipients' post-LT morbidity and mortality, a relationship that persists across all MELD scores. Center variability in post-LT healthcare utilization correlates with LT volume and the propensity to perform transplantation in higher risk candidates. Strategies that successfully reduce healthcare utilization before and after LT should continue to be explored, particularly with respect to preventable hospitalizations and differences in care practices across centers. Finally,, DAOH as a post-LT metric could provide a novel framework with which to educate patients about expectations after LT.
